Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, ...

Kiniksa Pharmaceuticals International PLC (NASDAQ:KNSA) is set to release its Q1 2025 earnings on Apr 29, 2025. The consensus ...

Intel plans workforce cuts and a tighter return-to-work policy, but the company, a major Arizona employer, didn't announce ...

Completed foreclosure auctions increased 20% from the previous quarter and 4% from a year earlier, despite some mid-quarter ...

Baron International Growth Fund increased in the first quarter of 2025, although it underperformed its benchmark, the MSCI ...

Read about Iridium's 5 percent growth in fiscal 2025 first quarter revenue and learn more about the financial results of its ...

Net profit before tax rises 33% YoY to AED 2.2 billion with net profit after tax rising 22% YoY to AED 1.9 billion. 1; Robust ...